Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…
Category: Lung Cancer Research
Get updated information about lung cancer research here. Browse to read the articles.
Research Finds Useful Information about Natural Killer Cells
The researchers of Trinity College Dublin based at St James’s Hospital have provided useful insights about the behaviour and metabolic function of *natural killer* immune cell resident in the lungs. Their findings…
Banning Tobacco Sales Could Significantly Reduce Lung Cancer Deaths
Smoking is the leading cause of preventable lung cancer related death worldwide. It is the biggest lung cancer risk factor and accounts for more than two-thirds of the 1.8 million deaths from…
New Study To Help Advance Research In Lung Cancer
23andMe Holding Co. is a leading genetic health and biopharmaceutical company. Lung Cancer Research Foundation (LCRF) in collaboration with 23andMe Holding Co, and 20 lung cancer advocacy organizations have announced a new…
Researchers Say Honeybees Can Detect Lung Cancer
According to Michigan State University researchers, honeybees may be able to develop a new form of cancer screening. Honeybees can detect chemicals associated with lung cancer in human breath. In their study,…
FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer
Every year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration…
World’s First Lung Cancer Vaccine is Being Developed by UK Researchers
Lung cancer is the deadliest form of cancers all around the world including Britain. Every year, around 50,000 cases and 35,000 deaths of patients with lung cancer are reported in Britain alone….
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients progress to advanced stages when it…